Immunomodulation with Nucleic Acid Nanodevices
Abstract
The precise regulation of interactions of specific immunological components is crucial for controllable immunomodulation, yet it remains a great challenge. With the assistance of advanced computer design, programmable nucleic acid nanotechnology enables the customization of synthetic nucleic acid nanodevices with unprecedented geometrical and functional precision, which have shown promising potential for precise immunoengineering. Notably, the inherently immunologic functions of nucleic acids endow these nucleic acid‐based assemblies with innate advantages in immunomodulatory engagement. In this review, the roles of nucleic acids in innate immunity are discussed, focusing on the definition, immunologic modularity, and enhanced bioavailability of structural nucleic acid nanodevices. In light of this, molecular programming and precise organization of functional modules with nucleic acid nanodevices for immunomodulation are emphatically reviewed. At last, the present challenges and future perspectives of nucleic acid nanodevices for immunomodulation are discussed.Keywords
Funding Information
- National Natural Science Foundation of China (22005136, 21991134, 91953106, 22122406)
- Natural Science Foundation of Shanghai Municipality (20ZR1425600)
- Science and Technology Commission of Shanghai Municipality (21dz2210100)
This publication has 188 references indexed in Scilit:
- A method to study in vivo stability of DNA nanostructuresMethods, 2013
- Mechanism for the endocytosis of spherical nucleic acid nanoparticle conjugatesProceedings of the National Academy of Sciences, 2013
- Methods for Evaluating Cell-Specific, Cell-Internalizing RNA AptamersPharmaceuticals, 2013
- Targeting 4-1BB Costimulation to Disseminated Tumor Lesions With Bi-specific Oligonucleotide AptamersMolecular Therapy, 2011
- A proximity-based programmable DNA nanoscale assembly lineNature, 2010
- Affinity threshold for thymic selection through a T-cell receptor–co-receptor zipperNature Reviews Immunology, 2009
- Immunotherapy of autoimmunity and cancer: the penalty for successNature Reviews Immunology, 2008
- Assembling OX40 Aptamers on a Molecular Scaffold to Create a Receptor-Activating AptamerChemistry & Biology, 2008
- Trivalent Ligands with Rigid DNA Spacers Reveal Structural Requirements For IgE Receptor Signaling in RBL Mast CellsACS Chemical Biology, 2007
- Spatiotemporal regulation of MyD88–IRF-7 signalling for robust type-I interferon inductionNature, 2005